KYMR
Kymera Therapeutics, Inc.
$121.13−0.39 (−0.32%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Aug 21, 2020 – Nov 18, 2026, Dividends reinvested
- Final balance
- $36,419
- CAGR
- +23.01%
- Max drawdown
- −87.51%
Trailing returns (%)
KYMR's average annual return was 14.32% over the last 5 years, through Nov 18, 2026. $10,000 in KYMR on Nov 18, 2021 grew to $19,528 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +15.60%
- 3M
- −0.21%
- 6M
- +52.04%
- YTD
- +55.67%
- 1Y
- +88.35%
Per year
- 3Y
- +84.05%
- 5Y
- +14.32%
- Since 2020
- +23.01%
Annual returns
2020 from Aug 21 · 2026 through Nov 18
KYMR returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +55.67% |
| 2025 | +93.41% |
| 2024 | +58.01% |
| 2023 | +2.00% |
| 2022 | −60.69% |
| 2021 | +2.40% |
| 2020 from Aug 21 | +86.41% |
Metrics
Since 2020| Volatility | 73.94% |
|---|---|
| Sharpe ratio | 0.64 |
| Sortino ratio | 1.01 |
| Calmar ratio | 0.26 |
| Longest drawdown | 4.9 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −87.5% | Dec 2020 | Oct 2023 | Dec 2025 | 4.9 years |
| −27.7% | Dec 2025 | Jan 2026 | Feb 2026 | 3 months |
| −25.0% | Feb 2026 | Jun 2026 | Jun 2026 | 4 months |
| −21.6% | Aug 2020 | Sep 2020 | Oct 2020 | 1 month |
| −17.7% | Aug 2026 | Oct 2026 | Nov 2026 | 2 months |